ID: ALA4456884

Max Phase: Preclinical

Molecular Formula: C47H50N6O6

Molecular Weight: 794.95

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21

Standard InChI:  InChI=1S/C47H50N6O6/c1-31(51-46(58)40(48)27-33-21-23-35(54)24-22-33)45(57)50-29-43(55)52-41(28-32-13-4-2-5-14-32)47(59)49-25-10-3-11-26-53-30-39(37-18-8-9-20-42(37)53)44(56)38-19-12-16-34-15-6-7-17-36(34)38/h2,4-9,12-24,30-31,40-41,54H,3,10-11,25-29,48H2,1H3,(H,49,59)(H,50,57)(H,51,58)(H,52,55)/t31-,40+,41+/m1/s1

Standard InChI Key:  ITROUYFUYPSKRI-DETMRDJISA-N

Associated Targets(non-human)

Cannabinoid receptor 174 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 6060 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Kappa opioid receptor 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 794.95Molecular Weight (Monoisotopic): 794.3792AlogP: 4.94#Rotatable Bonds: 19
Polar Surface Area: 184.65Molecular Species: NEUTRALHBA: 8HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.50CX Basic pKa: 7.73CX LogP: 5.12CX LogD: 4.76
Aromatic Rings: 6Heavy Atoms: 59QED Weighted: 0.05Np Likeness Score: -0.48

References

1. Dvorácskó S, Keresztes A, Mollica A, Stefanucci A, Macedonio G, Pieretti S, Zádor F, Walter FR, Deli MA, Kékesi G, Bánki L, Tuboly G, Horváth G, Tömböly C..  (2019)  Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors.,  178  [PMID:31220675] [10.1016/j.ejmech.2019.05.037]

Source